{"disease":{"id":"mild-to-moderate-psoriasis","name":"mild to moderate psoriasis"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05249972","title":"A Phase III Study in Subjects With Mild to Moderate Psoriasis.","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":294,"lead_sponsor_name":"Lipidor AB","has_results":false},{"nct_id":"NCT05174598","title":"A Clinical Trial to Evaluate Efficacy and Safety of Two Different Formulations of Topical Calcipotriol in Patients With Mild to Moderate Plaque Psoriasis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":278,"lead_sponsor_name":"Cadila Pharnmaceuticals","has_results":false},{"nct_id":"NCT03222622","title":"Study of Icotinib Hydrochloride Cream in Patients With Mild to Moderate Psoriasis","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":136,"lead_sponsor_name":"Betta Pharmaceuticals Co., Ltd.","has_results":false},{"nct_id":"NCT05965089","title":"A First in Human Study of AX-202 in Healthy Subjects and Patients With Psoriasis.","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":58,"lead_sponsor_name":"Arxx Therapeutics","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}